Characteristics | Number (%) |
---|---|
Surgery type | |
 Open | 34 (66.7) |
 laparoscopic | 17 (33.3) |
Re-operation on recurrence cases | 9 (17.6) |
Mitotane | 4 (7.8) |
Other (radiation, radiofrequency ablation, other chemotherapies) | 4 (7.8) |
Margin status (R1/2/X) | 13 (25.5) |
Duration of follow up – days (median, range) | 723 (117–3210) |
Survival status (during follow up) | |
 Recurrences | 24 (47.06) |
 Deaths | 33 (64.71) |